Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 127.50p 126.00p 129.00p 127.50p 127.50p 127.50p 5,203 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 20.3 135

Cello Health Share Discussion Threads

Showing 776 to 800 of 1075 messages
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
DateSubjectAuthorDiscuss
16/5/2014
12:50
at last some blue!
qs9
13/5/2014
19:51
Bug volume, hopefully seller cleared to allow this to properly rate!
qs99
13/5/2014
14:06
And 93p being paid now.
mintitan
13/5/2014
13:50
Another big buy; £277k bought around lunch time. Someone is obviously very keen and confident...
mintitan
13/5/2014
10:18
Agreed on all counts. IMO this is progressing nicely , using its cash wisely,is lowly geared and decent yield. Someone will IMO take a look at some point....
qs99
13/5/2014
09:05
Would have liked an acquisition in the US. How about Pfizer?
coopstock
13/5/2014
08:52
Ps Singer reiterates their 122p target this morning. Suggests 25% upside from current levels. At the current price, it trades at less the 9 X PBT to MCAP, pays a dividend and has a strong internationally growing established business! Looking forward to some nice press coverage and even a tip. Plus, theirs a good chance of a bid imo; the business is a lovely bolt on for one of the bigger boys at a steal.
mintitan
13/5/2014
08:37
Indeed QS9, rise is share price is certainly warranted. Looks like excellent value here and business is performing very strongly. Also, just noted a buy of £230k! Possibly director?
mintitan
13/5/2014
07:55
looks great, hopefully broker upgrades on this strong update and decent deal....IMO! let's see. Last TP from brokers i seem to recall was c.£1.20, so we are at a significant discount to that currently. today hopefully will see us march towards a quid...
qs9
13/5/2014
07:25
Superb trading update and acquisition to boot! Both segments of the business performing well and increasing opportunities in the US. New acquisition looks like a great fit and very good value too. Well done CLL!
mintitan
08/5/2014
08:16
Indeed marky. Interesting that the share price is now bouncing off the 50 day moving average nicely, in line with the positive uptrend.
mintitan
07/5/2014
20:33
AGM statement out on 13th May (as per Cello's website). An AGM statement is essentially a Trading Update. I expect a strong update from management focused on the performance of Consumer/Signal.
markyjacob123
07/5/2014
19:57
Very true! I have some QPP and def prefer here this last week, luckily still up there, but barely. Prefer a quiet board too, usually much more thoughtful!
cheeseandbiscuits
07/5/2014
12:17
I have the AGM statement in my diary pencilled in for Tuesday 13 May. Hopefully will provide some lift. Not going up a huge amount, but reassuring its not going down with the market weakness either.
mintitan
07/5/2014
10:03
Meh. This share hasn't budged at all since I bought in. Is there anything coming up soon that we know of?
cheeseandbiscuits
30/4/2014
09:05
Welcome cheeseandbiscuits and good luck!
mintitan
29/4/2014
18:58
Indeed. I paid 89!
cheeseandbiscuits
29/4/2014
13:49
Some nice buying today. c90p being paid now.
mintitan
25/4/2014
07:38
Nice acquisition announced this morning. Seems like a good fit with some strong new household name clients. Onwards and upwards.
mintitan
15/4/2014
11:45
Buys showing up as sells. Chart suggests a nice bounce.
mintitan
07/4/2014
08:59
Written up anywhere over the weekend?
speed_camera
07/4/2014
08:37
Some very strong buying this morning. Should support the next leg up nicely.
sagarn
02/4/2014
16:55
Thanks marky for the heads up! Great to see!
sagarn
02/4/2014
12:12
Cenkos upgrades Cello group Strong Delivery: Momentum in 2014 Cello Group has delivered a strong set of prelim results. This is reflected in terms of strong delivery across the whole group – with particularly strong growth in Cello Signal as it benefited from the improved economic outlook, a significant one-off rebranding project, and the full year contribution from Mash Healthcare. We upgrade our forecasts for FY2014 EPS by 2% to 7.4p, and publish new 2015E forecasts. BUY. Prelims vs. forecasts Revenues grew by 18.2% to £159.7m (2012: £135.1m) benefiting from good momentum in the global healthcare market and a strong return to growth for consumer - directly as a result of the stronger economic health of the UK economy. Gross profit of £74.7m (+14.8%, was well ahead of our forecasts of £69.7m). Headline PBT was £8.5m (+21.4%, beating our estimate of £8.4m. Headline EPS delivered was 7.25p (+13.8%) comfortably ahead of our forecasts of 6.84p. The final dividend for 2013 has been upgraded by 12.4%. The exit momentum exhibited by the group in Q4 2013 continues into '14. Cello Health 2013 was a strong year, benefiting from this increased activity positively impacting Cello Health's US business and is reflected in the numbers. The Cello Health re-branding exercise has been successfully implemented with new contract wins reflecting increased reach into the industry. The Mash acquisition has been particularly impressive driving sales growth and new business. Cello Signal (consumer) Cello Signal has had a highly successful year, enjoying a direct benefit from the growth in the UK economy. There has been an upswing in both the number and the quality of the contracts. Excluding a one off major branding contract, the underlying growth in revenues, gross profit and margins were at a double-digit level. The momentum and financial opportunity in Cello Signal is beginning to rival Cello Health and is now no longer dilutive to the group. Valuation We have used a comparable model to value both Cello Health and Cello Signal using closely related proxy companies. Combining both valuations on a blended PER delivers fair value for Cello Group share price of 143p (based on c.20x 2014E). Outlook & rating We upgrade our forecasts for 2014E: gross profit £76.6m vs. £72.4m [+6%], Adj. PBT £8.8m vs. £8.6m [+2%] and Adj. EPS 7.4p vs. 7.27p [+2%], and provide new 2015E forecasts for the first time. We reiterate our BUY rating.
markyjacob123
28/3/2014
09:58
Looking good, getting the recognition it deserves. First stop £1. Once it can crack that, £1.20 should be easily achieved.
sagarn
Chat Pages: 43  42  41  40  39  38  37  36  35  34  33  32  Older
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 21:34:53